Jae B. Kim's most recent trade in Avidity Biosciences Inc was a trade of 82,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 2, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Jae B. Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 82,000 | 82,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Jae B. Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 375,266 | 375,266 | - | - | Stock Option (Right to Buy) |